PA
GSK icon

PSI Advisors’s GSK GSK Stock Holding History

PSI Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-126
Closed -$4.24K – 828
2024
Q4 		$4.24K Buy
126
+1
+0.8% +$36 ﹤0.01% 644
2024
Q3 		$5.07K Buy
125
+2
+2% +$82 ﹤0.01% 656
2024
Q2 		$4.73K Buy
123
+1
+0.8% +$42 ﹤0.01% 648
2024
Q1 		$5.22K Buy
122
+1
+0.8% +$41 ﹤0.01% 589
2023
Q4 		$4.47K Sell
121
-775
-86% -$27.8K ﹤0.01% 645
2023
Q3 		$32.5K Buy
896
+2
+0.2% +$71 0.01% 310
2023
Q2 		$31.9K Buy
894
+1
+0.1% +$36 0.01% 313
2023
Q1 		$31.8K Buy
893
+1
+0.1% +$35 0.02% 276
2022
Q4 		$31.4K Sell
892
-719
-45% -$23.9K 0.02% 269
2022
Q3 		$47K Sell
1,611
-608
-27% -$23K 0.02% 233
2022
Q2 		$121K Sell
2,219
-43
-2% -$2.37K 0.06% 158
2022
Q1 		$123K Sell
2,262
-78
-3% -$4.24K 0.05% 178
2021
Q4 		$129K Sell
2,340
-98
-4% -$5.1K 0.05% 178
2021
Q3 		$116K Buy
+2,438
New +$122K 0.05% 185
2020
Q2 		– Sell
-5,790
Closed -$274K – 117
2020
Q1 		$274K Sell
5,790
-886
-13% -$47.3K 0.25% 80
2019
Q4 		$392K Buy
+6,676
New +$371K 0.25% 83

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PSI Advisors's GSK Position: Q1 2025 in Review

PSI Advisors sold out of GSK (GSK) in Q1 2025, closing a stake of 126 shares — an estimated $4.24K sold.

PSI Advisors first reported a position in GSK in Q4 2019 and held it in 16 quarters. The position peaked at $392K in Q4 2019. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • PSI Advisors reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • PSI Advisors sold 126 GSK shares in Q1 2025, an estimated $4.24K.
  • PSI Advisors first reported a position in GSK in Q4 2019 and held it in 16 quarters.
  • PSI Advisors's GSK position peaked at $392K in Q4 2019.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on PSI Advisors's 13F filing for Q1 2025, filed 21 Apr 2025.